Assessment of Physicochemical Properties of Rituximab Related to Its Immunomodulatory Activity

<table class="table-group" id="tab6"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td align="left">Arm</td><td align="center">Number of patients</td><td align="center">Positive HACAs patients</td><td align="center">Positive HACAs patients (%)</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td align="left">1</td><td align="center">15</td><td align="center">2</td><td align="center">13</td></tr><tr><td align="left">2</td><td align="center">13</td><td align="center">2</td><td align="center">15</td></tr><tr><td align="left">3</td><td align="center">31</td><td align="center">3</td><td align="center">10</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

HACAs determination in the immunogenicity study.

Journal of Immunology Research

tab6

Table 6

Table 6: Assessment of Physicochemical Properties of Rituximab Related to Its Immunomodulatory Activity 